![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Christopoulos, Petros; Kluck, Klaus; Kirchner, Martina; Lueders, Heike; Roeper, Julia; Falkenstern-Ge, Roger-Fei; Szewczyk, Marlen; Sticht, Florian; Saalfeld, Felix C.; Wesseler, Claas; Hackanson, Bjoern; Dintner, Sebastian; Faehling, Martin; Kuon, Jonas; Janning, Melanie; Kauffmann-Guerrero, Diego; Kazdal, Daniel; Kurz, Sylke; Eichhorn, Florian; Bozorgmehr, Farastuk; Shah, Rajiv; Tufman, Amanda; Wermke, Martin; Loges, Sonja; Brueckl, Wolfgang M.; Schulz, Christian; Misch, Daniel; Frost, Nikolaj; Kollmeier, Jens; Reck, Martin; Griesinger, Frank; Grohe, Christian; Hong, Jin-Liern; Lin, Huamao M.; Budczies, Jan; Stenzinger, Albrecht und Thomas, Michael
(2022):
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
In: European Journal of Cancer, Bd. 170: S. 106-118
Brueckl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Stenzinger, Albrecht; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2021):
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
In: Translational Lung Cancer Research, Bd. 10, Nr. 7: S. 3093-3106
Budczies, Jan; Kirchner, Martina; Kluck, Klaus; Kazdal, Daniel; Glade, Julia; Allgaeuer, Michael; Kriegsmann, Mark; Heussel, Claus-Peter; Herth, Felix J.; Winter, Hauke; Meister, Michael; Muley, Thomas; Goldmann, Torsten; Froehling, Stefan; Wermke, Martin; Waller, Cornelius F.; Tufman, Amanda; Reck, Martin; Peters, Solange; Schirmacher, Peter; Thomas, Michael; Christopoulos, Petros und Stenzinger, Albrecht
(2021):
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
In: Cancer Immunology Immunotherapy, Bd. 71, Nr. 2: S. 251-265
Frost, Nikolaj; Christopoulos, Petros; Kauffmann-Guerrero, Diego; Stratmann, Jan; Riedel, Richard; Schaefer, Monica; Alt, Jürgen; Gutz, Sylvia; Christoph, Daniel C.; Laack, Eckart; Faehling, Martin; Fischer, Richard; Fenchel, Klaus; Haen, Sebastian; Heukamp, Lukas; Schulz, Christian und Griesinger, Frank
(2021):
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 1758835920980558
Kazdal, Daniel; Rempel, Eugen; Oliveira, Cristiano; Allgaeuer, Michael; Harms, Alexander; Singer, Kerstin; Kohlwes, Elke; Ormanns, Steffen; Fink, Ludger; Kriegsmann, Joerg; Leichsenring, Michael; Kriegsmann, Katharina; Stoegbauer, Fabian; Tavernar, Luca; Leichsenring, Jonas; Volckmar, Anna-Lena; Longuespee, Remi; Winter, Hauke; Eichhorn, Martin; Heussel, Claus Peter; Herth, Felix; Christopoulos, Petros; Reck, Martin; Muley, Thomas; Weichert, Wilko; Budczies, Jan; Thomas, Michael; Peters, Solange; Warth, Arne; Schirmacher, Peter; Stenzinger, Albrecht und Kriegsmann, Mark
(2021):
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.
In: Translational Lung Cancer Research, Bd. 10, Nr. 4: S. 1666-1678
Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros; Merkelbach-Bruse, Sabine; Reissig, Timm M.; Lassmann, Silke; Thiel, Sebastian; Stratmann, Jan A.; Marienfeld, Ralf; Berger, Johannes; Desuki, Alexander; Velthaus, Janna-Lisa; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Michels, Sebastian; Herold, Thomas; Kramer, Michael; Herold, Sylvia; Tufman, Amanda; Loges, Sonja; Alt, Jürgen; Joosten, Maria; Schmidtke-Schrezenmeier, Gerlinde; Sebastian, Martin; Stephan-Falkenau, Susann; Waller, Cornelius F.; Wiesweg, Marcel; Wolf, Jürgen; Thomas, Michael; Aust, Daniela E. und Wermke, Martin
(2021):
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
In: Journal of Thoracic Oncology, Bd. 16, Nr. 11: S. 1952-1958
Brückl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2020):
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
In: Clinical Medicine Insights-Oncology, Bd. 14: S. 1-9
[PDF, 433kB]
Wessels, Sabine; Muley, Thomas; Christopoulos, Petros; Meister, Michael; Heinzmann-Groth, Ingrid; Warth, Arne; Herpel, Esther; Hummler, Simone; Klingmüller, Ursula; Kuon, Jonas; Heussel, Claus-Peter; Eberhardt, Ralf; Herth, Felix J. F.; Winter, Hauke; Bischoff, Helge; Stenzinger, Albrecht; Reck, Martin; Huber, Rudolf Maria; Thomas, Michael und Schneider, Marc A.
(2020):
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
In: Translational Lung Cancer Research, Bd. 9, Nr. 4: S. 1000-1014